FOXP3 and familial pancreatic carcinoma: We have previously shown that chimeric hMSLN-VLPs can effectively decrease tumor growth through a reduction in the frequency of CD4+foxp3+ Tregs in an orthotopic pancreatic cancer mouse model [21].